S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

NYSE:DLBDolby Laboratories Stock Price, Forecast & News

$70.17
+0.30 (+0.43 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$69.60
Now: $70.17▼
$70.22
50-Day Range
$64.65
MA: $67.06▼
$70.95
52-Week Range
$44.68
Now: $70.17▼
$73.94
Volume478,132 shs
Average Volume447,887 shs
Market Capitalization$7.06 billion
P/E Ratio29.00
Dividend Yield1.26%
Beta0.89
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications; Dolby TrueHD, a digital audio coding technology providing encoding for Blu-ray discs and home theaters; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Read More
Dolby Laboratories logo

Beat the Market (BTM) Rank™

Analyst Opinion: 1.4Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 2.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.83 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Patent owners & lessors
Sub-IndustryElectronic Components
SectorConsumer Discretionary
Current SymbolNYSE:DLB
Previous Symbol
CUSIP25659T10
CIK1308547
Webwww.dolby.com
Phone415-558-0200

Debt

Debt-to-Equity RatioN/A
Current Ratio5.83
Quick Ratio4.66

Price-To-Earnings

Trailing P/E Ratio29.00
Forward P/E Ratio31.19
P/E Growth2.4

Sales & Book Value

Annual Sales$1.24 billion
Price / Sales5.69
Cash Flow$3.41 per share
Price / Cash Flow20.56
Book Value$24.21 per share
Price / Book2.90

Profitability

EPS (Most Recent Fiscal Year)$2.44
Net Income$255.15 million
Net Margins20.89%
Return on Equity10.67%
Return on Assets8.73%

Miscellaneous

Employees2,193
Outstanding Shares100,658,000
Market Cap$7.06 billion
Next Earnings Date11/12/2020 (Estimated)
OptionableOptionable
$70.17
+0.30 (+0.43 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DLB News and Ratings via Email

Sign-up to receive the latest news and ratings for DLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Dolby Laboratories (NYSE:DLB) Frequently Asked Questions

How has Dolby Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DLB shares have increased by 16.5% and is now trading at $70.17.
View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Dolby Laboratories?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Dolby Laboratories.

When is Dolby Laboratories' next earnings date?

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Dolby Laboratories.

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories, Inc. (NYSE:DLB) announced its quarterly earnings results on Monday, August, 3rd. The electronics maker reported $0.86 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.13 by $0.73. The electronics maker earned $246.91 million during the quarter, compared to analyst estimates of $232.61 million. Dolby Laboratories had a net margin of 20.89% and a return on equity of 10.67%. The company's revenue for the quarter was down 18.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.76 earnings per share.
View Dolby Laboratories' earnings history.

How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?

Dolby Laboratories declared a quarterly dividend on Tuesday, August 4th. Stockholders of record on Monday, August 17th will be given a dividend of $0.22 per share on Wednesday, August 26th. This represents a $0.88 annualized dividend and a yield of 1.25%. The ex-dividend date is Friday, August 14th.
View Dolby Laboratories' dividend history.

What guidance has Dolby Laboratories issued on next quarter's earnings?

Dolby Laboratories updated its fourth quarter earnings guidance on Monday, August, 3rd. The company provided earnings per share guidance of $0.22-0.37 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.42. The company issued revenue guidance of $225-255 million, compared to the consensus revenue estimate of $251.94 million.

What price target have analysts set for DLB?

5 brokerages have issued 12-month target prices for Dolby Laboratories' shares. Their forecasts range from $65.00 to $83.00. On average, they anticipate Dolby Laboratories' share price to reach $73.67 in the next year. This suggests a possible upside of 5.0% from the stock's current price.
View analysts' price targets for Dolby Laboratories.

Has Dolby Laboratories been receiving favorable news coverage?

News coverage about DLB stock has trended very positive on Friday, according to InfoTrie. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Dolby Laboratories earned a media sentiment score of 4.0 on InfoTrie's scale. They also assigned news headlines about the electronics maker a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Dolby Laboratories.

Are investors shorting Dolby Laboratories?

Dolby Laboratories saw a decrease in short interest in July. As of July 31st, there was short interest totaling 1,240,000 shares, a decrease of 13.9% from the July 15th total of 1,440,000 shares. Based on an average daily volume of 422,700 shares, the days-to-cover ratio is currently 2.9 days. Approximately 1.9% of the shares of the company are sold short.
View Dolby Laboratories' Current Options Chain.

Who are some of Dolby Laboratories' key competitors?

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Vishay Intertechnology (VSH) and Rogers (ROG).
View all competitors.

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include Metlife (MET), AT&T (T), Netflix (NFLX), Comcast (CMCSA), Walt Disney (DIS), Activision Blizzard (ATVI), Brighthouse Financial (BHF), InterDigital Wireless (IDCC), Las Vegas Sands (LVS) and Hasbro (HAS).

Who are Dolby Laboratories' key executives?

Dolby Laboratories' management team includes the following people:
  • Mr. Kevin J. Yeaman, Pres, CEO & Director (Age 53)
  • Mr. Lewis Chew, Principal Financial Officer (Age 56)
  • Mr. Andy Sherman, Exec. VP, Gen. Counsel & Corp. Sec. (Age 52)
  • Mr. Todd Pendleton, Sr. VP & Chief Marketing Officer (Age 47)
  • Mr. Giles Baker, Sr. VP of Consumer Entertainment (Age 43)

What is Dolby Laboratories' stock symbol?

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Who are Dolby Laboratories' major shareholders?

Dolby Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include Marathon Asset Management LLP (0.79%), Obermeyer Wood Investment Counsel Lllp (0.60%), Trinity Street Asset Management LLP (0.50%), Sumitomo Mitsui Trust Holdings Inc. (0.48%), New York State Common Retirement Fund (0.43%) and KAMES CAPITAL plc (0.29%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories.

Which institutional investors are selling Dolby Laboratories stock?

DLB stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Sumitomo Mitsui Trust Holdings Inc., UBS Group AG, Trinity Street Asset Management LLP, Stone Ridge Asset Management LLC, NN Investment Partners Holdings N.V., Unigestion Holding SA, and NN Investment Partners Holdings N.V.. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories.

Which institutional investors are buying Dolby Laboratories stock?

DLB stock was bought by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Marathon Asset Management LLP, Obermeyer Wood Investment Counsel Lllp, Seizert Capital Partners LLC, Pembroke Management LTD, WINTON GROUP Ltd, Swiss National Bank, and Naples Global Advisors LLC.
View insider buying and selling activity for Dolby Laboratories.

How do I buy shares of Dolby Laboratories?

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dolby Laboratories' stock price today?

One share of DLB stock can currently be purchased for approximately $70.17.

How big of a company is Dolby Laboratories?

Dolby Laboratories has a market capitalization of $7.06 billion and generates $1.24 billion in revenue each year. The electronics maker earns $255.15 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,193 workers across the globe.

What is Dolby Laboratories' official website?

The official website for Dolby Laboratories is www.dolby.com.

How can I contact Dolby Laboratories?

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]

This page was last updated on 8/7/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.